Renpenning syndrome

Renpenning syndrome, also known as Sutherland-Haan syndrome, Cerebropalatocardiac syndrome, or Golabi-Ito-Hall syndrome, is a rare X-linked intellectual disability syndrome caused by mutations in the PQBP1 (polyglutamine-binding protein 1) gene located on chromosome Xp11.23. The condition predominantly affects males and is characterized by moderate to severe intellectual disability, microcephaly (abnormally small head), short stature, and lean body habitus. Affected individuals typically have a distinctive facial appearance that may include long narrow face, upslanting palpebral fissures, cup-shaped ears, a short philtrum, and midface hypoplasia. Small testes (testicular hypoplasia) are a common feature in affected males. The syndrome primarily affects the central nervous system, with intellectual disability being the hallmark feature. Speech and language development are significantly delayed, and many affected individuals have limited or absent speech. Some patients may also exhibit behavioral abnormalities, including autistic features. Additional findings can include cardiac defects, cleft palate, and ocular anomalies, though these are variable. Brain imaging may reveal structural abnormalities. Female carriers are typically unaffected or may show mild cognitive difficulties. There is currently no cure or specific treatment for Renpenning syndrome. Management is supportive and multidisciplinary, focusing on early intervention programs, speech therapy, occupational therapy, and special education to maximize developmental potential. Regular monitoring of growth parameters, cardiac evaluation, and ophthalmologic assessments are recommended. Genetic counseling is important for affected families to understand the X-linked recessive inheritance pattern and recurrence risks.

Common questions about Renpenning syndrome